Calcineurin Inhibitors: Current Role, Toxicity Management, and Future Frontiers in Immunosuppression

Area of Science:

• Immunology
• Pharmacology

Background:

• Calcineurin inhibitors (CNIs) are potent immunosuppressants used in organ transplantation and autoimmune diseases.
• CNIs function by inhibiting the calcineurin phosphatase pathway, which impairs T-cell activation.

Purpose of the Study:

• To review the mechanisms, clinical applications, and safety concerns of calcineurin inhibitors (CNIs).
• To explore future directions for the safer and targeted use of CNIs.

Main Methods:

• This narrative review synthesizes existing literature on CNIs.
• Key aspects covered include CNI mechanism, applications, and adverse effects.

Main Results:

• CNIs effectively suppress T-cell activation, vital for managing transplants and autoimmune conditions.
• Common side effects include nephrotoxicity, hypertension, neurotoxicity, and metabolic disturbances, necessitating continuous drug monitoring and risk factor management.

Conclusions:

• CNIs are essential immunosuppressants but pose significant safety risks.
• Future research should focus on developing safer, targeted CNI therapies and improved patient monitoring strategies.